News | June 10, 2026
Viyash Scientific to acquire Italy’s BioForLife for Rs. 188 crore
The acquisition of Milan-based company will strengthen subsidiary Alivira Animal Health’s presence in Europe
The acquisition of Milan-based company will strengthen subsidiary Alivira Animal Health’s presence in Europe
Pharma industry veteran brings more than two decades of experience in sales, marketing, business development, and global market expansion to his new leadership role
Pharma industry veteran brings extensive experience in commercial strategy, business growth, and market leadership to his expanded role at Cipla
Mohit Yadav reaffirmed government's commitment to improve competitiveness, enhance export capabilities and support the country's transition from volume-driven to value-driven exports
The move makes EBGLYSS the only therapy offering as few as six maintenance injections per year
The company says the goal is to improve consistency and efficiency in total hip arthroplasty (THA) as demand for the procedure continues to surge
Strategic collaboration aims to strengthen clinical capabilities, enhance patient experience and improve fertility treatment outcomes through scientific expertise, technology and data-driven care
Preclinical CRO strengthens leadership team with key executive appointments as it scales its human tissue-based drug discovery platform
Strategic shift from Italy to India strengthens supply chain resilience, expands capacity and enhances sustainability for the growing global UDCA market
Clara Sattler de Sousa e Brito to lead discovery solutions from Q3 2026, while Robert Machinek takes over as Head of Strategy & Business Development
Subscribe To Our Newsletter & Stay Updated
